Prognostic scoring models in parotid gland carcinoma
Marie Westergaard-Nielsen1,2, Sören Möller2,3, Christian Godballe1,2
1Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark.
Head & Neck
|March 18, 2021
Summary
Identifying prognostic factors for parotid gland carcinoma recurrence is crucial. A validated prognostic model can help personalize follow-up strategies for patients after curative treatment.
Area of Science:
- Oncology
- Head and Neck Surgery
- Cancer Prognostics
Background:
- Parotid gland carcinoma is a rare malignancy.
- Accurate prognostication is essential for effective patient management.
- Current prognostic models require validation for recurrence risk prediction.
Purpose of the Study:
- To identify key prognostic factors for parotid gland carcinoma recurrence.
- To evaluate the predictive accuracy of three established prognostic scoring models.
- To determine the optimal model for predicting recurrence-free survival.
Main Methods:
- Retrospective analysis of 726 Danish patients with parotid gland carcinoma treated with curative intent (1990-2015).
- Cox regression and competing risk analyses were used to assess prognostic factors.
- Harrel's C index was employed to evaluate model concordance with observed outcomes.
Main Results:
- Significant predictors of reduced recurrence-free survival included advanced age (>60 years), high-grade histology, T3/T4 tumors, lymph node metastases, and positive surgical margins.
- The best-performing prognostic model demonstrated a concordance index (C-index) of 0.76.
- The study identified specific clinical and pathological factors associated with poorer outcomes.
Conclusions:
- Prognostic scoring models can significantly enhance individualized follow-up strategies for parotid gland carcinoma patients.
- Validated models aid in risk stratification and personalized treatment planning.
- Further research may refine these models for broader clinical application.
